|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.235 USD | -1.98% |
|
-1.20% | -32.88% |
| Apr. 09 | Biodesix, Inc. announced that it has received $34.999422 million in funding | CI |
| Apr. 05 | Top Midday Decliners | MT |
Biodesix, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 49.09 million compared to USD 38.21 million a year ago. Net loss was USD 52.15 million compared to USD 65.45 million a year ago.
Basic loss per share from continuing operations was USD 0.64 compared to USD 1.55 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.88% | 140M | |
| -17.89% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
BIODESIX, INC. 
